To evaluate the risk of myocardial infarction (MI) after receiving intravitreal bevacizumab
(IVB) injection. We retrospectively reviewed the charts of patients who had received IVB
injection in 2016, and grouped them according to whether they received the injection for age-
related macular degeneration (AMD), diabetes-related complications, or retinal vein
occlusion (RVO). We then investigated the prevalence of MI within 2 months after IVB
injection and analyzed the possible association of IVB with MI. During 2016, 724 patients …